Viking Therapeutics, Inc. ( VKTX) - Stock Earnings
VKTX Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Oct. 28, 2026, midnight | — / — | — | — / — | — |
VKTX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -157.7 million USD | — USD |
| 2026Q1 | -158.3 million USD | — USD |
| 2026Q2 | -128.0 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
VKTX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -85.9 million USD | — USD |
| 2024 | -110.0 million USD | — USD |
| 2025 | -359.6 million USD | — USD |
| 2026 Est. | — | — |
VKTX
Price: $25.47
52 week price:
Earnings Per Share: -4.67 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.7 million
Ebitda: -4.7 millionMarket Capitalization: 3.5 billion